Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy [corrected].
about
Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in childrenAnti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenAddition to inhaled corticosteroids of long-acting beta 2-agonists versus anti-leukotrienes for chronic asthmaAddition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in childrenLong-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthmaEfficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma.Allergic rhinitis: evidence for impact on asthmaImproving outcomes for asthma patients with allergic rhinitis: conclusions from the MetaForum conferencesCurrent trends in the treatment of asthma: focus on the simultaneous administration of salmeterol/fluticasone.Major comorbid conditions in asthma and association with asthma-related hospitalizations and emergency department admissions in adults: results from the German National Health Telephone Interview Survey (GEDA) 2010.The impact of allergic rhinitis on the management of asthma in a working population.The minimal clinically important difference of the Control of Allergic Rhinitis and Asthma Test (CARAT): cross-cultural validation and relation with pollen counts.The predictors of poorly controlled asthma in elderly.Montelukast as an alternative to low-dose inhaled corticosteroids in the management of mild asthma (the SIMPLE trial): an open-label effectiveness trial.Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial)Managing co-morbid asthma with allergic rhinitis: targeting the one-airway with leukotriene receptor antagonists.Asthma in patients with Japanese cedar pollinosis.Allergic Rhinitis and Its Impact on Asthma in Asia Pacific and the ARIA Update 2008Burden of concomitant allergic rhinitis in adults with asthma.Montelukast in asthma: a review of its efficacy and place in therapy.Mouse Sensitivity is an Independent Risk Factor for Rhinitis in Children with Asthma.Novel therapeutic interventions for allergic rhinitis.Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN.Association between allergic rhinitis and asthma control in Peruvian school children: a cross-sectional study.Allergic Rhinitis: A neglected disease - A community based assessment among adults in DelhiBurden of Respiratory Disease in Korea: An Observational Study on Allergic Rhinitis, Asthma, COPD, and Rhinosinusitis.Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control.Respiratory diseases and the impact of cough in Taiwan: Results from the APBORD observational study.Evaluating combination therapies for asthma: pros, cons, and comparative benefits.The burden of segregated respiratory diseases in India and the quality of care in these patients: Results from the Asia-Pacific Burden of Respiratory Diseases study.Allergic rhinitis: the "Ghost Diagnosis" in patients with asthma.Protocol for a systematic review to identify and weight the indicators of risk of asthma exacerbations in children aged 5-12 years.Investigational drugs for allergic rhinitis.Impact of comorbidities on asthma.Montelukast in the treatment of asthma and beyond.Emerging drugs for perennial allergic rhinitis.Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.Omalizumab for treatment of allergic rhinitis.Assessing the risk of attack in the management of asthma: a review and proposal for revision of the current control-centred paradigm.
P2860
Q24187686-D1850677-C57B-4026-B59F-AEC1F8A7DB08Q24197682-43D95131-4917-4FE5-A3F3-931C627856EEQ24200999-5258F5B3-5166-4CCC-87F3-628D3D84B1D3Q24234499-56CA0872-CD72-4FAD-A709-4128838BF7D2Q24239922-42B21A46-C874-41C2-8A23-6259D3D162EAQ24244152-8A5559FB-5D2F-4846-8FF0-0F98D25F9526Q30360466-EDB00269-66A4-4642-9F64-03041E7015F5Q33265228-EB67479E-47EF-40AE-AD5F-AD329E490062Q33265231-363639B3-E7A5-4494-9E26-DE55EA1CAF99Q34620194-961064A1-A789-40A1-8E08-ED5835E61A1CQ34816040-9379633A-9EE0-4B06-97D4-4388300D9209Q35836749-6059303A-E7B1-441E-B696-21D890A0F5AAQ35939334-0E9D326D-0FFF-406C-94B1-036D5241B6CDQ36177340-1B8AB718-5245-443F-9A6F-E60E483D5858Q36364525-198B9446-9E87-4FFC-8C0B-1FFD4AFF35ABQ36364534-C65DFA9E-2075-47DC-8316-8669C8E328DEQ36371018-FC2E6861-5B24-407D-9CC5-25493E99C6C6Q36371023-8E6DF56D-D180-4DAC-A171-D161CEFBBBDEQ36371027-2CEA76EF-E9A7-471E-999A-DD4249E6273AQ36383019-900977B5-9FA4-45C1-AA52-9B8ACA70E9C4Q36443703-09FC4D8A-D2BD-4395-A910-581E3A132400Q36471430-C2E20BF6-CD4A-4578-B355-9014061AC49EQ36654345-812A15EF-139A-4F5D-BE7F-499434D1370CQ36966123-B936662D-AF50-4178-8A4C-8D777E34F7C2Q37091017-79B653D5-6705-4DEB-8887-0DB4F982C0FBQ37091200-0EDD2EBC-2A00-4758-8B23-22818754707BQ37231358-1EFBCE59-90ED-4D86-9AAD-BE7EA64A7F44Q37274731-DB67AD71-961B-4A7A-B31E-3038383ACE05Q37327870-4266063C-FAC4-422B-9591-76255FCB2F83Q37362610-A5AAD086-982E-405E-AB13-216C3FC3E0B9Q37419627-B0C73CD4-5C15-42F8-8A5F-C49F67FDC149Q37481236-F7D54A33-E847-465C-8D5C-BA937B8426FFQ37560263-7D46374E-5F61-4326-A514-26470A270AA8Q37650382-E1D599B2-32F6-4D85-A8A4-46987CE1B9F3Q37754787-DC80572B-4BCE-4C48-8AB2-7FC6279E0BCAQ37755326-988ACE83-9C66-443D-A59C-3184B790E1FEQ38062942-52CD2D0E-F924-4DAB-A8F1-EE0A8E947CFCQ38099379-3932EBDE-6A4B-46C2-B799-C3066A2BF1FDQ38101972-007457D8-23A7-4C6A-92A1-45F365BA3557Q38118606-0812837B-13E6-4C50-8F83-33693C70D87B
P2860
Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy [corrected].
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Increased risk of asthma attac ...... lementary therapy [corrected].
@en
Increased risk of asthma attac ...... lementary therapy [corrected].
@nl
type
label
Increased risk of asthma attac ...... lementary therapy [corrected].
@en
Increased risk of asthma attac ...... lementary therapy [corrected].
@nl
prefLabel
Increased risk of asthma attac ...... lementary therapy [corrected].
@en
Increased risk of asthma attac ...... lementary therapy [corrected].
@nl
P2093
P2860
P1476
Increased risk of asthma attac ...... lementary therapy [corrected].
@en
P2093
J Bousquet
V Sazonov Kocevar
P2860
P304
P356
10.1111/J.1365-2222.2005.02251.X
P50
P577
2005-06-01T00:00:00Z